Sialyllactose Attenuates Inflammation and Injury of Intestinal Epithelial Cells upon Enterotoxigenic Escherichia coli Infection
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083860 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Qiming Duan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611130, China. Hauptthemen laut MEDLINE: Enterotoxigenic Escherichia coli, Escherichia coli Infections, Intestinal Mucosa, Epithelial Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Innovation Team of Sichuan Province.
Abstract (Originalsprache)
Sialyllactose (SL), a bioactive trisaccharide abundant in porcine colostrum, demonstrates multifunctional properties including antimicrobial activity, immune regulation, and apoptosis inhibition. This research uncovers the mechanisms by which SL mitigates enterotoxigenic Escherichia coli (ETEC)-mediated damage to intestinal barrier integrity, employing IPEC-J2 porcine epithelial models. SL pre-treatment effectively blocked pathogen adhesion by competitively binding to cellular receptors, concurrently mitigating inflammation through significant suppression of TNF-α, IL-1β, and IL-6 expression (p < 0.05). Notably, SL exhibited functional parallels to the NF-κB inhibitor BAY11-7082, jointly enhancing tight junction integrity via ZO-1 protein stabilization and inhibiting pro-inflammatory signaling through coordinated suppression of IκB-α/NF-κB phosphorylation cascades. The dual-action mechanism combines molecular interception of microbial attachment with intracellular modulation of the TLR4/MyD88/NF-κB pathway, effectively resolving both pathogenic colonization and inflammatory amplification. These findings position SL as a potential therapeutic application nutraceutical for livestock, with the capacity to address post-weaning porcine enteritis through functional feed formulations that synergistically enhance intestinal barrier resilience while curbing ETEC-mediated inflammatory pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611130, China.
- Key Laboratory for Animal Disease-Resistance Nutrition, Chengdu 611130, China.
ORCID-Profile: Bing Yu, Zhiqing Huang, Xiangbing Mao, Jie Yu, Hui Yan, Jun He
Förderung
- National Natural Science Foundation of China
- Innovation Team of Sichuan Province
Zitieren
APA
Duan, Q., Yu, B., Huang, Z., Luo, Y., Zheng, P., Mao, X., Yu, J., Luo, J., Yan, H., & He, J. (2025). Sialyllactose Attenuates Inflammation and Injury of Intestinal Epithelial Cells upon Enterotoxigenic Escherichia coli Infection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083860
Vancouver
Duan Q, Yu B, Huang Z, Luo Y, Zheng P, Mao X, et al. Sialyllactose Attenuates Inflammation and Injury of Intestinal Epithelial Cells upon Enterotoxigenic Escherichia coli Infection. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083860
BibTeX
@article{Duan2025,
author = {Duan, Qiming and Yu, Bing and Huang, Zhiqing and Luo, Yuheng and Zheng, Ping and Mao, Xiangbing and Yu, Jie and Luo, Junqiu and Yan, Hui and He, Jun},
title = {Sialyllactose Attenuates Inflammation and Injury of Intestinal Epithelial Cells upon Enterotoxigenic Escherichia coli Infection},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083860}
}
EUVIMED